Bat genomes illuminate adaptations to viral tolerance and disease resistance

Ariadna E. Morales, Yue Dong, Thomas Brown, Kaushal Baid, Dimitrios Georgios Kontopoulos, Victoria Gonzalez, Zixia Huang, Alexis Walid Ahmed, Arkadeb Bhuinya, Leon Hilgers, Sylke Winkler, Graham Hughes, Xiaomeng Li, Ping Lu, Yixin Yang, Bogdan M. Kirilenko, Paolo Devanna, Tanya M. Lama, Yomiran Nissan, Martin PippelLiliana M. Dávalos, Sonja C. Vernes, Sebastien J. Puechmaille, Stephen J. Rossiter, Yossi Yovel, Joseph B. Prescott, Andreas Kurth, David A. Ray, Burton K. Lim, Eugene Myers, Emma C. Teeling, Arinjay Banerjee, Aaron T. Irving*, Michael Hiller*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Zoonoses are infectious diseases transmitted from animals to humans. Bats have been suggested to harbour more zoonotic viruses than any other mammalian order1. Infections in bats are largely asymptomatic2,3, indicating limited tissue-damaging inflammation and immunopathology. To investigate the genomic basis of disease resistance, the Bat1K project generated reference-quality genomes of ten bat species, including potential viral reservoirs. Here we describe a systematic analysis covering 115 mammalian genomes that revealed that signatures of selection in immune genes are more prevalent in bats than in other mammalian orders. We found an excess of immune gene adaptations in the ancestral chiropteran branch and in many descending bat lineages, highlighting viral entry and detection factors, and regulators of antiviral and inflammatory responses. ISG15, which is an antiviral gene contributing to hyperinflammation during COVID-19 (refs. 4,5), exhibits key residue changes in rhinolophid and hipposiderid bats. Cellular infection experiments show species-specific antiviral differences and an essential role of protein conjugation in antiviral function of bat ISG15, separate from its role in secretion and inflammation in humans. Furthermore, in contrast to humans, ISG15 in most rhinolophid and hipposiderid bats has strong anti-SARS-CoV-2 activity. Our work reveals molecular mechanisms that contribute to viral tolerance and disease resistance in bats.

Original languageEnglish
Article number7360
Pages (from-to)449-458
Number of pages10
JournalNature
Volume638
Issue number8050
DOIs
StatePublished - 13 Feb 2025

Funding

FundersFunder number
National Science Foundation
Toronto Zoological Society
Max-Planck-Gesellschaft
Canada Foundation for Innovation
Robert Koch Institut
BATSPEAK
Institut universitaire de France
Ministry of Agriculture of the People's Republic of China
Technische Universität Dresden
Government of Saskatchewan
Zhejiang University–University of Edinburgh Institute
Center for Molecular and Cellular Bioengineering
UK Research and InnovationMR/T021985/1
Deutsche ForschungsgemeinschaftHI1423/5-1
Natural Science Foundation of Zhejiang ProvinceZ23C010003
NSF-IOS2031906, 2032063
Natural Sciences and Engineering Research Council of CanadaRGPIN-2022-03010
National Science Foundation Research Fund for International Excellent Young Scientists82350610279
Royal Ontario Museum GovernorsDEB-0344430
Hessisches Ministerium für Wissenschaft und KunstLOEWE/1/10/519/03/03.001(0014)/52, INST 269/768-1
European Molecular Biology OrganizationALTF 1089-2021
Irish Research CouncilIRCLA/2017/58
Science Foundation Ireland19/FFP/6790
Canadian Institutes of Health Research569587-2022, PEE-183995, PTT-192089
European Research Council101001702
NSF-DEB2010853, 1838273

    Fingerprint

    Dive into the research topics of 'Bat genomes illuminate adaptations to viral tolerance and disease resistance'. Together they form a unique fingerprint.

    Cite this